Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
The Oncologist
|
February 10, 2024
Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer
Sana Kagalwalla, Alexander K Tsai, Manju George, et al.
Journal of Bone Oncology
|
September 27, 2021
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer
Mark Clemons, Michelle Liu, Carol Stober, et al.
The Lancet. Global Health
|
October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
Kristina Jenei, Zeba Aziz, Christopher Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma
Alison C Young, Rachel A Craven, Dena Cohen, et al.
Gut
|
January 24, 2012
Cell and organ bioengineering technology as applied to gastrointestinal diseases
Giuseppe Orlando, Juan Domínguez-Bendala, Thomas Shupe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2020
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
Mark Clemons, Michael Ong, Carol Stober, et al.
JAMA Oncology
|
June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis
Alexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.
Nature Medicine
|
August 8, 2022
Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care
Fabio Ynoe de Moraes, Gustavo Nader Marta, Gunita Mitera, et al.
The Lancet. Oncology
|
February 1, 2024
Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study
Megan McLeod, Julie Torode, Kari Leung, et al.
Biomaterials
|
May 18, 2013
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies
Giuseppe Orlando, Christopher Booth, Zhan Wang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
The Oncologist
|
February 10, 2024
Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer
Sana Kagalwalla, Alexander K Tsai, Manju George, et al.
Journal of Bone Oncology
|
September 27, 2021
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer
Mark Clemons, Michelle Liu, Carol Stober, et al.
The Lancet. Global Health
|
October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
Kristina Jenei, Zeba Aziz, Christopher Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma
Alison C Young, Rachel A Craven, Dena Cohen, et al.
Gut
|
January 24, 2012
Cell and organ bioengineering technology as applied to gastrointestinal diseases
Giuseppe Orlando, Juan Domínguez-Bendala, Thomas Shupe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2020
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
Mark Clemons, Michael Ong, Carol Stober, et al.
JAMA Oncology
|
June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis
Alexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.
Nature Medicine
|
August 8, 2022
Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care
Fabio Ynoe de Moraes, Gustavo Nader Marta, Gunita Mitera, et al.
The Lancet. Oncology
|
February 1, 2024
Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study
Megan McLeod, Julie Torode, Kari Leung, et al.
Biomaterials
|
May 18, 2013
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies
Giuseppe Orlando, Christopher Booth, Zhan Wang, et al.
Page
of 7